Skip to main content

Table 1 Baseline characteristics of study population (n = 370)

From: The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial

Characteristics

Preeclampsia within 7 days (n = 42)

No preeclampsia within 7 days (n = 328)

Maternal age at recruitment (in years), Mean (SD)

31.2 (5.8)

31.2 (6.1)

Gestational age (in weeks), Median (IQR)

35.3 (33.4—36.1)

34.1 (31.1—35.9)

BMI (in kg/m2), Median (IQR)

27.3 (24.5—31.7)

27.3 (23.9—32)

Parity

 Nulliparous

35 (83.3%)

145 (44.2%)

 Multiparous

7 (16.7%)

183(55.8%)

Smoking status

 Current smoker

2 (4.8%)

31 (9.4%)

 Never smoker

24 (57.1%)

201 (61.3%)

 Previous smoker

16 (38.1%)

96 (29.3%)

Ethnicity

 White British

37 (88.1%)

295 (89.9%)

 Other

5 (11.9%)

33 (10.1%)

a sFlt-1, Median (IQR)

4.03 (3.88—4.15)

3.38 (3.18 – 3.61)

a PIGF, Median (IQR)

1.87 (1.72 – 2.07)

2.40 (2.17 -2.73)

a sFlt-1/PIGF ratio, Median (IQR)

2.11 (1.82 – 2.35

0.89 (0.56 – 1.44)

sFlt-1/PIGF cut off

 Ratio ≤ 38

1 (2.4%)

256 (78.1%)

 Ratio > 38

41 (97.6%)

72 (21.9%)

  1. SD Standard deviation, PIGF Placental growth factor, sFlt-1 Soluble fms-like tyrosine kinase-1, IQR Interquartile range, BMI Body mass index, BP Blood pressure
  2. asFlt-1, PIGF and the sFlt-1/PIGF ratio reported on natural log scale